➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
AstraZeneca
Express Scripts
Colorcon
Merck

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

ZYLOPRIM Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Zyloprim, and when can generic versions of Zyloprim launch?

Zyloprim is a drug marketed by Casper Pharma Llc and is included in one NDA.

The generic ingredient in ZYLOPRIM is allopurinol. There are twenty-two drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the allopurinol profile page.

US ANDA Litigation and Generic Entry Outlook for Zyloprim

A generic version of ZYLOPRIM was approved as allopurinol by WATSON LABS on September 28th, 1984.

  Start Trial

Drug patent expirations by year for ZYLOPRIM
Drug Prices for ZYLOPRIM

See drug prices for ZYLOPRIM

Drug Sales Revenue Trends for ZYLOPRIM

See drug sales revenues for ZYLOPRIM

Recent Clinical Trials for ZYLOPRIM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Instituto Nacional de Cardiologia Ignacio ChavezPhase 3
Instituto Nacional de RehabilitacionPhase 3
Salvador López GilPhase 2

See all ZYLOPRIM clinical trials

Pharmacology for ZYLOPRIM

US Patents and Regulatory Information for ZYLOPRIM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Casper Pharma Llc ZYLOPRIM allopurinol TABLET;ORAL 016084-001 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial   Start Trial
Casper Pharma Llc ZYLOPRIM allopurinol TABLET;ORAL 016084-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ZYLOPRIM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Casper Pharma Llc ZYLOPRIM allopurinol TABLET;ORAL 016084-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Casper Pharma Llc ZYLOPRIM allopurinol TABLET;ORAL 016084-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Boehringer Ingelheim
Mallinckrodt
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.